Diagnostic Performance of Plasma Biomarkers in the Outpatient Memory Clinic
Dr. Trey Bateman and Dr. Gregg Day discuss the study design, findings, and clinical implications of using plasma biomarkers in real-world patient care. Show reference
Read the full articleYou might also wanna read
IFM | Innovative Diagnostic Tools and Workflows for Suspected Alzheimer's in Primary Care
In this special edition of Inside Family Medicine , sponsored by Roche Diagnostics, h ost Darren Sextro talks with brain health experts Dean

Alzheimer’s biomarkers in dental practice: Is innovation outpacing readiness?
Practices should be cautious about adopting complex biomarker tests such as APOE genotyping and blood-based Tau assays. Here's why.
Potential use for blood biomarkers in dementia diagnosis where medical resources are limited
Blood biomarkers are highly accessible for use in diagnosis, and there is very strong potential for them to be valuable in low- and middle-i
The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Disease
Conditions : Alzheimer Blood Biomarkers; Alzheimer's Disease (AD) Interventions : Diagnostic Test: Plasma p-tau217 and neurofilament light c
Plasma proteomic signatures enable risk prediction of early retinal neurodegeneration in type 2 diabetes
In a observational multi-cohort study, Wei Wang and colleagues identify circulating plasma protein signatures of diabetic retinal neurodegen
Navigating Biomarker Conversations: Empowering Patient Understanding in Gastroesophageal Cancer
How confident are you navigating biomarker conversations with your gastric cancer patients?

Comments
Sign in to join the conversation.
No comments yet. Be the first.